A series of 3-amino-substituted rutacecarpine derivatives were synthesized to identify novel multitarget-directed ligands for the treatment of Alzheimer's disease.
Biological evaluation showed that most of synthesized compounds inhibited butyrylcholinesterase.
Biological evaluation showed that most of synthesized compounds exerted antioxidant effects.
Among synthesized compounds, 6n was subjected to further biological evaluation.
Lineweaver-Burk plotting illustrated that 6n bound simultaneously to catalytic sites of butyrylcholinesterase.
Lineweaver-Burk plotting illustrated that 6n bound simultaneously to peripheral anionic site of butyrylcholinesterase.
molecular modeling illustrated that 6n bound simultaneously to peripheral anionic site of butyrylcholinesterase.
molecular modeling illustrated that 6n bound simultaneously to catalytic site of butyrylcholinesterase.
Furthermore, 6n modulated amyloid-beta aggregation; chelated biometals; showed remarkable neuroprotective activity.
Furthermore, 6n modulated amyloid-beta aggregation; chelated biometals; presented good metabolism property.
Furthermore, 6n modulated amyloid-beta aggregation; chelated biometals; showed remarkable neuroprotective activity.
Furthermore, 6n modulated amyloid-beta aggregation; chelated biometals; presented good absorption property.
Furthermore, 6n modulated amyloid-beta aggregation; chelated biometals; showed remarkable neuroprotective activity.
Furthermore, 6n modulated amyloid-beta aggregation; chelated biometals; presented good excretion property.
Furthermore, 6n modulated amyloid-beta aggregation; chelated biometals; showed remarkable neuroprotective activity.
Furthermore, 6n modulated amyloid-beta aggregation; chelated biometals; presented good distribution property.
Furthermore, 6n modulated amyloid-beta aggregation; chelated biometals; presented toxicity property.
Furthermore, 6n modulated amyloid-beta aggregation; chelated biometals; showed remarkable neuroprotective activity.
Previous research has shown that optimized compound 6n has considerable potential for development as an novel multitarget-directed ligand for the treatment of Alzheimer's disease.
















